Office of the Director, National Institutes of Health; Notice of Meeting, 8332 [08-634]
Download as PDF
<![CDATA[
8332
Federal Register / Vol. 73, No. 30 / Wednesday, February 13, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biomedical Library
and Informatics Review Committee.
Date: June 12–13, 2008.
Time: June 12, 2008, 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Time: June 13, 2008, 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, Board Room, 2nd Floor, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: Arthur A Petrosian, PhD,
Scientific Review Administrator, Division of
Extramural Programs, National Library of
Medicine, 6705 Rockledge Drive, Suite 301,
Bethesda, MD 20892–7968, 301–496–4253,
petrosia@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: February 6, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–635 Filed 2–12–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
rwilkins on PROD1PC63 with NOTICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of meeting of the
Recombinant DNA Advisory Committee.
VerDate Aug<31>2005
17:45 Feb 12, 2008
Jkt 214001
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact person listed below
in advance of the meeting.
Name of Committee: Recombinant DNA
Advisory Committee.
Date: March 11–12, 2008.
Time: March 11, 2008, 8 a.m. to 4:30 p.m.
Agenda: The Recombinant DNA Advisory
Committee will review and discuss selected
human gene transfer protocols as well as
related data management activities. This will
include an update on new developments in
gene transfer for X–SCID.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Floor 6C, Room
6, Bethesda, MD 20892.
Time: March 12, 2008, 8 a.m. to 3 p.m.
Agenda: The Recombinant DNA Advisory
Committee will review and discuss selected
human gene transfer protocols as well as
related data management activities.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Floor 6C, Room
6, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Advisory
Committee Coordinator, Office of
Biotechnology Activities, National Institutes
of Health, 6705 Rockledge Drive, Room 750,
Bethesda, MD 20892–7985, (301) 496–9838,
lewallla@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
http:www4.od.nih.gov/oba/, where an agenda
and any additional information for the
meeting will be posted when available.
OMB’s ‘‘Mandatory Information
Requirements for Federal Assistance Program
Announcements’’ (45 FR 39592, June 11,
1980) requires a statement concerning the
official government programs contained in
the Catalog of Federal Domestic Assistance.
Normally NIH lists in its announcements the
number and title of affected individual
programs for the guidance of the public.
Because the guidance in this notice covers
virtually every NIH and Federal research
program in which DNA recombinant
molecule techniques could be used, it has
been determined not to be cost effective or
in the public interest to attempt to list these
programs. Such a list would likely require
several additional pages. In addition, NIH
could not be certain that every Federal
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
program would be included as many Federal
agencies, as well as private organizations,
both national and international, have elected
to follow the NIH Guidelines. In lieu of the
individual program listing, NIH invites
readers to direct questions to the information
address above about whether individual
programs listed in the Catalog of Federal
Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: February 6, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–634 Filed 2–12–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Access to Recovery (ATR)
Program (OMB No. 0930–0266)—
Revision
The Center for Substance Abuse
Treatment (CSAT) is charged with
implementing the Access to Recovery
(ATR) program which will allow
grantees (States, Territories, the District
of Columbia and Tribal Organizations) a
means to implement voucher programs
for substance abuse clinical treatment
and recovery support services. The ATR
program is part of a Presidential
initiative to: (1) Provide client choice
among substance abuse clinical
treatment and recovery support service
providers, (2) expand access to a
comprehensive array of clinical
treatment and recovery support options
(including faith-based programmatic
options), and (3) increase substance
E:\FR\FM\13FEN1.SGM
13FEN1
]]>Agencies
[Federal Register Volume 73, Number 30 (Wednesday, February 13, 2008)]
[Notices]
[Page 8332]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-634]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: March 11-12, 2008.
Time: March 11, 2008, 8 a.m. to 4:30 p.m.
Agenda: The Recombinant DNA Advisory Committee will review and
discuss selected human gene transfer protocols as well as related
data management activities. This will include an update on new
developments in gene transfer for X-SCID.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Floor 6C, Room 6, Bethesda, MD 20892.
Time: March 12, 2008, 8 a.m. to 3 p.m.
Agenda: The Recombinant DNA Advisory Committee will review and
discuss selected human gene transfer protocols as well as related
data management activities.
Place: National Institutes of Health, Building 31, 31 Center
Drive, Floor 6C, Room 6, Bethesda, MD 20892.
Contact Person: Laurie Lewallen, Advisory Committee Coordinator,
Office of Biotechnology Activities, National Institutes of Health,
6705 Rockledge Drive, Room 750, Bethesda, MD 20892-7985, (301) 496-
9838, lewallla@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: http:www4.od.nih.gov/oba/, where an agenda and any additional
information for the meeting will be posted when available.
OMB's ``Mandatory Information Requirements for Federal
Assistance Program Announcements'' (45 FR 39592, June 11, 1980)
requires a statement concerning the official government programs
contained in the Catalog of Federal Domestic Assistance. Normally
NIH lists in its announcements the number and title of affected
individual programs for the guidance of the public. Because the
guidance in this notice covers virtually every NIH and Federal
research program in which DNA recombinant molecule techniques could
be used, it has been determined not to be cost effective or in the
public interest to attempt to list these programs. Such a list would
likely require several additional pages. In addition, NIH could not
be certain that every Federal program would be included as many
Federal agencies, as well as private organizations, both national
and international, have elected to follow the NIH Guidelines. In
lieu of the individual program listing, NIH invites readers to
direct questions to the information address above about whether
individual programs listed in the Catalog of Federal Domestic
Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: February 6, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-634 Filed 2-12-08; 8:45 am]
BILLING CODE 4140-01-M
